Puma names new CEO with immediate effect as Gulden heads to Adidas | Nasdaq
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2022 Earnings Call Transcript - Insider Monkey
Fenty x PUMA is Back | Nasdaq
AeroVironment debuts Puma VNS SUAS that enables GPS-denied navigation across GPS-contested environments – SatNews
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Buy Puma Biotechnology Inc stock & View ($PBYI) Share Price on eToro.
We Think Puma Biotechnology (NASDAQ:PBYI) Is Taking Some Risk With Its Debt
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2023
Nasdaq BehindtheBell Interview with Mary Puma - YouTube
Nasdaq stock market " Cap for Sale by 2MB- | Redbubble
The Billion Dollar Molecule (NASDAQ:PBYI) | Seeking Alpha
Puma raises sales outlook despite supply challenges | Nasdaq
We Think Puma Biotechnology (NASDAQ:PBYI) Can Stay On Top Of Its Debt - Simply Wall St News
PUMA Ranked Most Sustainable Brand on Business of Fashion Sustainability Index 2022 | Nasdaq
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Puma reports strong sales despite port congestion, politics | Nasdaq
Puma confirms operating profit, sales outlook after Q3 results | Nasdaq
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
0% Leather. 110% KING - PUMA Phases out K-Leather With Innovative K-BETTER™ Technology. | Nasdaq
Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology to Move Stock Exchange Listing to Nasdaq
Puma sees 2023 profit at about last year's level as costs weigh | Nasdaq
